Astellas to acquire gene therapy firm Audentes for $3 billion
Wednesday, December 4, 2019 - 13:20
in Mathematics & Economics
The latest acquisition suggests M&A is back for gene therapy
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via